A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients

J.J. Eron, C. Orkin, J. Gallant, J.-M. Molina, E. Negredo, A. Antinori, A. Mills, J. Reynes, E. Van Landuyt, E. Lathouwers, V. Hufkens, J. Jezorwski, S. Vanveggel, M. Opsomer

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1431-1442
Number of pages12
JournalAIDS
Volume32
Issue number11
DOIs
Publication statusPublished - 2018

Cite this

A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients. / Eron, J.J.; Orkin, C.; Gallant, J.; Molina, J.-M.; Negredo, E.; Antinori, A.; Mills, A.; Reynes, J.; Van Landuyt, E.; Lathouwers, E.; Hufkens, V.; Jezorwski, J.; Vanveggel, S.; Opsomer, M.

In: AIDS, Vol. 32, No. 11, 2018, p. 1431-1442.

Research output: Contribution to journalArticle

Eron, JJ, Orkin, C, Gallant, J, Molina, J-M, Negredo, E, Antinori, A, Mills, A, Reynes, J, Van Landuyt, E, Lathouwers, E, Hufkens, V, Jezorwski, J, Vanveggel, S & Opsomer, M 2018, 'A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients', AIDS, vol. 32, no. 11, pp. 1431-1442. https://doi.org/10.1097/QAD.0000000000001817
Eron, J.J. ; Orkin, C. ; Gallant, J. ; Molina, J.-M. ; Negredo, E. ; Antinori, A. ; Mills, A. ; Reynes, J. ; Van Landuyt, E. ; Lathouwers, E. ; Hufkens, V. ; Jezorwski, J. ; Vanveggel, S. ; Opsomer, M. / A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients. In: AIDS. 2018 ; Vol. 32, No. 11. pp. 1431-1442.
@article{d24c8ad0425e49f7af6e4d472e30a1aa,
title = "A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients",
author = "J.J. Eron and C. Orkin and J. Gallant and J.-M. Molina and E. Negredo and A. Antinori and A. Mills and J. Reynes and {Van Landuyt}, E. and E. Lathouwers and V. Hufkens and J. Jezorwski and S. Vanveggel and M. Opsomer",
note = "Cited By :3 Export Date: 4 September 2018",
year = "2018",
doi = "10.1097/QAD.0000000000001817",
language = "English",
volume = "32",
pages = "1431--1442",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "11",

}

TY - JOUR

T1 - A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients

AU - Eron, J.J.

AU - Orkin, C.

AU - Gallant, J.

AU - Molina, J.-M.

AU - Negredo, E.

AU - Antinori, A.

AU - Mills, A.

AU - Reynes, J.

AU - Van Landuyt, E.

AU - Lathouwers, E.

AU - Hufkens, V.

AU - Jezorwski, J.

AU - Vanveggel, S.

AU - Opsomer, M.

N1 - Cited By :3 Export Date: 4 September 2018

PY - 2018

Y1 - 2018

U2 - 10.1097/QAD.0000000000001817

DO - 10.1097/QAD.0000000000001817

M3 - Article

VL - 32

SP - 1431

EP - 1442

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 11

ER -